Ambulatory Routine Care in Oncology in Germany: Real-World Survival Data. 24. Mai 2024 Marschner N, Knauf W. Oncol Res Treat. 2024 Mar 15:1-11. doi: 10.1159/000536652. Epub ahead of print. Abstract Tucatinib in patients with locally advanced or metastatic HER2-positive breast cancer who received at least two prior ant-HER2 treatment regimens. Study Design of the non-interventional study TRACE in Germany and Austria. A Nusch, M Angerer, M Welslau, C Uleer, J Radosa, D Wrobel, S Noeding, K Apel, J Terhaag, I Tamm, L Bauer, M Balic, D… Weiterlesen Changes in survival of >3.800 patients with metastatic colorectal cancer in Germany: Results from 16-year prospective longitudinal real-world data analysis Marschner N, Seufferlein T, Potthoff K, Zahn MO, Uhlig J, Dörfel S, Karcher A, Sauer A, Maintz C, Fruehauf S, Hutzschenreuter U, Tech S, Grafetstätter… Weiterlesen